These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6548907)

  • 1. Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.
    Lewis RA; Schoenwald RD; Eller MG; Barfknecht CF; Phelps CD
    Arch Ophthalmol; 1984 Dec; 102(12):1821-4. PubMed ID: 6548907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of ocular hypotensive effect of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
    Lu DW; Chiang CH; Kao KD; Wen LY
    J Ocul Pharmacol; 1990; 6(4):271-8. PubMed ID: 2097310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topically active carbonic anhydrase inhibitors. 1. O-acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide.
    Woltersdorf OW; Schwam H; Bicking JB; Brown SL; deSolms SJ; Fishman DR; Graham SL; Gautheron PD; Hoffman JM; Larson RD
    J Med Chem; 1989 Nov; 32(11):2486-92. PubMed ID: 2810337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension.
    Lewis RA; Schoenwald RD; Barfknecht CF; Phelps CD
    Arch Ophthalmol; 1986 Jun; 104(6):842-4. PubMed ID: 3521557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical carbonic anhydrase inhibitors.
    Kass MA
    Am J Ophthalmol; 1989 Mar; 107(3):280-2. PubMed ID: 2923154
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminozolamide suspension: the role of the vehicle in a topical carbonic anhydrase inhibitor.
    Lewis RA; Schoenwald RD; Barfknecht CF
    J Ocul Pharmacol; 1988; 4(3):215-9. PubMed ID: 3198983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
    Kao KD; Lu DW; Chiang CH; Huang HS
    J Ocul Pharmacol; 1990; 6(4):313-20. PubMed ID: 2097315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical carbonic anhydrase inhibitors.
    Schoenwald RD; Eller MG; Dixson JA; Barfknecht CF
    J Med Chem; 1984 Jun; 27(6):810-2. PubMed ID: 6737424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-amino-2-benzothiazole-sulfonamide. The effect of a topical carbonic anhydrase inhibitor on aqueous humor formation in the normal human eye.
    Kalina PH; Shetlar DJ; Lewis RA; Kullerstrand LJ; Brubaker RF
    Ophthalmology; 1988 Jun; 95(6):772-7. PubMed ID: 3211479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
    J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular disposition of aminozolamide in the rabbit eye.
    Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
    Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations among IOP reduction, ocular disposition and pharmacology of the carbonic anhydrase inhibitor ethoxzolamide.
    Maren TH; Brechue WF; Bar-Ilan A
    Exp Eye Res; 1992 Jul; 55(1):73-9. PubMed ID: 1397133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical explanation for the topical activity of 6-hydroxyethoxy-2-benzothiazolesulfonamide in the rabbit eye.
    Lee DY; Schoenwald RD; Barfknecht CF
    J Ocul Pharmacol; 1992; 8(3):247-65. PubMed ID: 1453087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
    Gelatt KN; Gum G; Williams LW; Gwin RM
    Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of topical and general anesthesia on ocular drug levels and intraocular pressure lowering activity of topically applied carbonic anhydrase inhibitors.
    Bar-Ilan A; Pessah NI
    J Ocul Pharmacol; 1988; 4(1):1-12. PubMed ID: 3171330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151.
    Bar-Ilan A; Pessah NI; Maren TH
    J Ocul Pharmacol; 1986; 2(2):109-20. PubMed ID: 3503100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical carbonic anhydrase inhibitors. III: Optimization model for corneal penetration of ethoxzolamide analogues.
    Eller MG; Schoenwald RD; Dixson JA; Segarra T; Barfknecht CF
    J Pharm Sci; 1985 Feb; 74(2):155-60. PubMed ID: 3989684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.